Market Place
Sourcing Support
Health Canada Issues Recall of Donepezil 10 mg Tablet
27 Nov 2023 //
HEALTH CANADA
Corium Announces Publication of Favorable ADLARITY Skin Irritation Trial Data
12 Sep 2023 //
PR NEWSWIRE
Corium, Lotus Pharmaceutical Partner on Alzheimer`s Drug Adlarity
10 Aug 2023 //
CONTRACT PHARMA
Xiamen`s Generic Memantine, Donepezil Receives Approval in the U.S.
07 Apr 2023 //
FDA
Corium Announces Publication of ADLARITY Clinical Trial Data
19 Sep 2022 //
PRNEWSWIRE
KemPharm Earns $1.975 M Fee from Corium Following FDA Approval of ADLARITY
16 Mar 2022 //
GLOBENEWSWIRE
FDA Approves Corium`s ADLARITY in Alzheimer`s Disease
14 Mar 2022 //
PRNEWSWIRE
Icure Acquires Drug Product Approval for World’s First Donepezil Patch in Korea
16 Nov 2021 //
BUSINESSWIRE
Enforcement Report - Week of September 8, 2021
08 Sep 2021 //
FDA
Granules India, Jubilant Cadista recall products in US market
11 Aug 2021 //
BUSINESS-STANDARD
People often skip neurological meds when out-of-pocket costs rise
20 Feb 2020 //
REUTERS
Morton Grove`s Withdrawal of Approval of 21 Abbreviated New Drug Applications
02 Dec 2019 //
FEDERALREGISTER
Celltrion to start phase 3 clinical trials for patch-type donepezil
04 Nov 2019 //
THE INVESTOR
What does the past generation of failure in Alzheimer’s R&D look like
24 Apr 2019 //
ENDPTS
Local drug makers strive to conquer neurological diseases
10 Jul 2018 //
KOREA BIOMED
Eisai accelerates dementia drug discovery research
18 Jun 2018 //
PHARMAPHORUM
Eisai partners with Chong Kun Dang for drug sales
05 Jun 2018 //
BIOSPECTRUM ASIA
Corium close to partnering on transdermal Alzheimer’s drug
20 Nov 2017 //
IN PHARMATECHNOLOGIST
Axovant Much-Hyped Alzheimer`s Drug Flunks Phase III Test
27 Sep 2017 //
BIOSPACE
Cadila Pharms Ltd Generic Donepezil Hydrochloride Receives Approval In Us
22 Sep 2017 //
FDA
Enforcement Report - Week of May 3, 2017
03 May 2017 //
FDA
Neurotrope announces +ve top-line results from phase 2 study of Bryostatin-1
02 May 2017 //
PHARMABIZ
Amneal`s Generic Donepezil HCL; Memantine HCL Receives Approval In US
27 Jan 2017 //
FDA
Eisai`s Lenvima moves toward Nexavar showdown with phase 3 liver cancer win
26 Jan 2017 //
FIERCE PHARMA
Eisai, Keio University enter joint research pact to discover & develop new drugs
27 Dec 2016 //
PHARMABIZ
Allergan chases high-dose, low side effects Alzheimer’s combo in biotech buy
23 Nov 2016 //
FIERCE BIOTECH
Allergan broadens Alzheimer`s campaign after expanding Namzaric indication
21 Nov 2016 //
FIERCE PHARMA
Unichem`s Generic Donepezil HCL Receives Approval In US
10 Nov 2016 //
FDA
Allergan & Adamas Announce U.S Availability of New Dosage Strengths for NAMZARIC
22 Sep 2016 //
PR NEWSWIRE
Allergan and Adamas Announce New Expanded Indication for NAMZARIC
19 Jul 2016 //
PR NEWSWIRE
Unichem Labs` Generic Donepezil Approved in US For cognition in Alzheimer`s
23 Jun 2016 //
FDA
Eisai gains Philippines approval for Aricept in new license
16 Apr 2016 //
FIERCE PHARMA
Indicus’ Generic Aricept Approval Reveals Potential for U.S. Government Sales
15 Apr 2016 //
TWOFOUR INSIGHT
Indicus Pharma`s Generic Donepezil HCl approved in US to treat dementia
12 Apr 2016 //
FDA
Lupin launches generic Aricept tablets in US market
31 Mar 2016 //
ECONOMIC TIMES
Chase Pharma raises $12M for Alzheimer`s R&D
29 Mar 2016 //
FIERCE BIOTECH
Pharma`s DTC ad spending soars past $5B in 2015
07 Mar 2016 //
FIERCE PHARMA MARKETING
ANI Pharma and Dexcel Announce FDA Approval of Donepezil HCl 23mg Tablets
24 Feb 2016 //
PR NEWSWIRE
Dementia prescriptions six times higher than a decade ago
19 Jan 2016 //
PHARMATIMES
Singapore`s TauRx mulls Nasdaq IPO & sees future for Alzheimer`s treatment
06 Jan 2016 //
FIERCE PHARMA ASIA
Adamas soars as its Parkinson`s drug comes through in Phase III
23 Dec 2015 //
FIERCE BIOTECH
Health Canada warns potential,allergic reactions to OTC topical products
17 Dec 2015 //
FDA
Struggling Eisai looks for help in China with new generics deal
04 Dec 2015 //
FIERCE PHARMA
Allergan counting on January formulary boost to jump-start Namzaric launch
11 Nov 2015 //
FIERCE PHARMA MARKETING
Allergan, shut down on Namenda hard switch, takes it up with SCOTUS
11 Nov 2015 //
FIERCE PHARMA
Lupin`s Generic Donepezil HCL approved in US for Alzheimer
30 Oct 2015 //
FDA
Mylan`s Generic Donepezil HCl approved in US for Alzheimer`s Disease
22 Oct 2015 //
FDA
Novartis, Allergan Alzheimer`s meds linked to abnormal behavior
10 Oct 2015 //
FIERCE PHARMA
Roche CEO: Big Data needs Big Pharma, and vice versa
06 Oct 2015 //
FIERCE PHARMA
Allergan`s H2 looks lighter without generics, but 10% growth on tap for 2016
30 Sep 2015 //
FIERCE PHARMA
Takeda crosses Actos settlement threshold as 96% of plaintiffs seek resolution
14 Sep 2015 //
FIERCE PHARMA ASIA
Sun`s Generic Donepezil Hcl (23Mg) Approved in US For Dementia
06 Jun 2015 //
FDA
UPDATED: Eisai to Shed 200-plus Jobs as it Pares Down U.S. Workforce
10 Apr 2015 //
FIERCE PHARMA
AdverseEvents: Analysis of side-effect reports turns up troubling safety signals for Novartis, Eisai drugs
07 Apr 2015 //
FIERCE PHARMA
Abu Faour Sues Pharmaceutical Companies
14 Mar 2015 //
THE DAILY STAR
